Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
AstraZeneca
Fuji
Healthtrust
McKesson
Baxter
Federal Trade Commission
Moodys
Argus Health
Daiichi Sankyo

Generated: January 22, 2018

DrugPatentWatch Database Preview

Alosetron hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for alosetron hydrochloride and what is the scope of alosetron hydrochloride freedom to operate?

Alosetron hydrochloride
is the generic ingredient in two branded drugs marketed by Amneal Pharms, West-ward Pharms Int, and Sebela Ireland Ltd, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for alosetron hydrochloride. Six suppliers are listed for this compound.
Pharmacology for alosetron hydrochloride

US Patents and Regulatory Information for alosetron hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sebela Ireland Ltd LOTRONEX alosetron hydrochloride TABLET;ORAL 021107-002 Dec 23, 2003 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int ALOSETRON HYDROCHLORIDE alosetron hydrochloride TABLET;ORAL 200652-001 May 4, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int ALOSETRON HYDROCHLORIDE alosetron hydrochloride TABLET;ORAL 200652-002 May 4, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amneal Pharms ALOSETRON HYDROCHLORIDE alosetron hydrochloride TABLET;ORAL 206647-001 Dec 22, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amneal Pharms ALOSETRON HYDROCHLORIDE alosetron hydrochloride TABLET;ORAL 206647-002 Dec 22, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sebela Ireland Ltd LOTRONEX alosetron hydrochloride TABLET;ORAL 021107-001 Feb 9, 2000 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for alosetron hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sebela Ireland Ltd LOTRONEX alosetron hydrochloride TABLET;ORAL 021107-002 Dec 23, 2003 ➤ Subscribe ➤ Subscribe
Sebela Ireland Ltd LOTRONEX alosetron hydrochloride TABLET;ORAL 021107-001 Feb 9, 2000 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
QuintilesIMS
Medtronic
Daiichi Sankyo
US Department of Justice
McKesson
Harvard Business School
Federal Trade Commission
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot